| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Oxalylglycine | 5262-39-5 | sc-202720 sc-202720A | 10 mg 100 mg | $53.00 $153.00 | 5 | |
N-Oxalylglycine (CAS 5262-39-5) is a chemical compound known for its role as an inhibitor of HIF PHD1 (Hypoxia-Inducible Factor Prolyl Hydroxylase 1). It exerts its action by inhibiting the hydroxylation of HIF (Hypoxia-Inducible Factor) proteins, which are critical regulators of cellular responses to low oxygen levels. By targeting PHD1, N-Oxalylglycine can potentially modulate the cellular response to hypoxia and impact various oxygen-sensitive processes. | ||||||
N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine-d3 | 808118-40-3 unlabeled | sc-488006 | 10 mg | $12000.00 | ||
N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine-d3 acts as an inhibitor of HIF-PHD1, effectively mimicking hypoxic conditions within cells. This action stabilizes hypoxia-inducible factors (HIFs), leading to increased transcription of erythropoietin (EPO) and promoting red blood cell production. The mechanism of inhibition disrupts the normal oxygen-sensing capabilities of the cell, facilitating the endogenous production of EPO. | ||||||
BAY 85-3934 | 1154028-82-6 | sc-507384 | 5 mg | $205.00 | ||
Roxadustat (FG-4592) acts as an inhibitor of HIF-PHD1, effectively mimicking hypoxic conditions within cells. This action stabilizes hypoxia-inducible factors (HIFs), leading to increased transcription of erythropoietin (EPO) and promoting red blood cell production. The mechanism of inhibition disrupts the normal oxygen-sensing capabilities of the cell, facilitating the endogenous production of EPO. | ||||||